TLB-33

AssetAlso MT-2990

Binds and neutralizes IL-33 to potentially preserve thymic function and enhance immune resilience.

Stage
Human trials
Modality
Antibody
Target
IL33
1
Indication
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains1
  • Owner and partners1
  • Evidence for its targets1
  • Competitors1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets